At week @ of the trial , @ ( @ % ) of the @ venlafaxine + bright light therapy patients versus just @ ( @ % ) of the @ venlafaxine patients ( P < @ ) attained the target goal of treatment , a HDRS score @ , indicative of mild depression , and , although not statistically significant in our small sample study ( P = @ ) , at week @ , @ % of venlafaxine + bright light therapy patients ( n = @ ) versus just @ % of the venlafaxine patients ( n = @ ) experienced complete remission of depression ( HDRS score @ ) .